Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CKM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R13L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD3EAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC3L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BLOC1S3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAPPC6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NKPD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on